SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '4drt'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site

Query pattern: Residues from known binding site for annotated drug that match the hit pattern


(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)
Filter list by:
DrReposER ID / Desc. Hit
PDBID
Hit
Macromolecule
Res.
Matches
Interface HETATM RMSD Dali
Z-score
Seq.
Identity (%)
View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1MXG_A_ACRA442_1
(ALPHA AMYLASE)
4drt DE NOVO DESIGNED
SERINE HYDROLASE,
OR89

(synthetic
construct)
5 / 11 GLU A 355
GLN A 325
GLY A 284
GLY A 356
ASP A 285
None
0.98A 1mxgA-4drtA:
undetectable
1mxgA-4drtA:
21.26
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1Q8J_B_C2FB802_0
(5-METHYLTETRAHYDROFO
LATE S-HOMOCYSTEINE
METHYLTRANSFERASE)
4drt DE NOVO DESIGNED
SERINE HYDROLASE,
OR89

(synthetic
construct)
5 / 12 SER A 238
ILE A 237
GLY A 212
ASN A 200
ILE A 213
None
1.19A 1q8jB-4drtA:
undetectable
1q8jB-4drtA:
21.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1R9O_A_FLPA501_1
(CYTOCHROME P450 2C9)
4drt DE NOVO DESIGNED
SERINE HYDROLASE,
OR89

(synthetic
construct)
5 / 12 ILE A 104
VAL A  98
ASP A 114
ALA A 116
THR A  51
None
1.03A 1r9oA-4drtA:
undetectable
1r9oA-4drtA:
21.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2C12_C_SPMC1434_1
(NITROALKANE OXIDASE)
4drt DE NOVO DESIGNED
SERINE HYDROLASE,
OR89

(synthetic
construct)
5 / 12 LEU A 320
GLU A 279
ALA A 277
LEU A 315
VAL A 314
None
1.18A 2c12C-4drtA:
undetectable
2c12C-4drtA:
24.89
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2E7F_A_C2FA3000_0
(5-METHYLTETRAHYDROFO
LATE CORRINOID/IRON
SULFUR PROTEIN
METHYLTRANSFERASE)
4drt DE NOVO DESIGNED
SERINE HYDROLASE,
OR89

(synthetic
construct)
5 / 12 ILE A 237
LEU A 257
GLY A 212
ASN A 200
ILE A 213
None
1.17A 2e7fA-4drtA:
undetectable
2e7fA-4drtA:
22.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2E7F_B_C2FB4000_0
(5-METHYLTETRAHYDROFO
LATE CORRINOID/IRON
SULFUR PROTEIN
METHYLTRANSFERASE)
4drt DE NOVO DESIGNED
SERINE HYDROLASE,
OR89

(synthetic
construct)
5 / 12 ILE A 237
LEU A 257
GLY A 212
ASN A 200
ILE A 213
None
1.20A 2e7fB-4drtA:
undetectable
2e7fB-4drtA:
22.29
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3EEY_C_SAMC300_1
(PUTATIVE RRNA
METHYLASE)
4drt DE NOVO DESIGNED
SERINE HYDROLASE,
OR89

(synthetic
construct)
3 / 3 ASN A  81
ASP A 111
GLN A 110
None
0.76A 3eeyC-4drtA:
undetectable
3eeyC-4drtA:
22.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3EEY_D_SAMD300_1
(PUTATIVE RRNA
METHYLASE)
4drt DE NOVO DESIGNED
SERINE HYDROLASE,
OR89

(synthetic
construct)
3 / 3 ASN A  81
ASP A 111
GLN A 110
None
0.77A 3eeyD-4drtA:
undetectable
3eeyD-4drtA:
22.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3EEY_E_SAME300_1
(PUTATIVE RRNA
METHYLASE)
4drt DE NOVO DESIGNED
SERINE HYDROLASE,
OR89

(synthetic
construct)
3 / 3 ASN A  81
ASP A 111
GLN A 110
None
0.77A 3eeyE-4drtA:
undetectable
3eeyE-4drtA:
22.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3EKV_A_478A200_2
(PROTEASE)
4drt DE NOVO DESIGNED
SERINE HYDROLASE,
OR89

(synthetic
construct)
5 / 9 ALA A  76
GLY A 112
ILE A 107
VAL A  98
ILE A  72
None
1.06A 3ekvB-4drtA:
undetectable
3ekvB-4drtA:
15.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3FC6_C_REAC501_1
(RETINOIC ACID
RECEPTOR RXR-ALPHA)
4drt DE NOVO DESIGNED
SERINE HYDROLASE,
OR89

(synthetic
construct)
5 / 12 VAL A 117
ALA A 123
ALA A 124
LEU A 133
ALA A  58
None
0.98A 3fc6C-4drtA:
undetectable
3fc6C-4drtA:
23.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3G59_A_ACTA306_0
(FMN
ADENYLYLTRANSFERASE)
4drt DE NOVO DESIGNED
SERINE HYDROLASE,
OR89

(synthetic
construct)
4 / 5 SER A  52
MET A 214
PHE A 184
ILE A 107
None
0.99A 3g59A-4drtA:
undetectable
3g59A-4drtA:
20.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3ITA_D_AICD501_1
(D-ALANYL-D-ALANINE
CARBOXYPEPTIDASE
DACC)
4drt DE NOVO DESIGNED
SERINE HYDROLASE,
OR89

(synthetic
construct)
3 / 3 PRO A 269
PHE A 276
ALA A 311
None
0.24A 3itaD-4drtA:
41.7
3itaD-4drtA:
60.72
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3L35_H_DHIH3_0
(GP41 N-PEPTIDE
HIV ENTRY INHIBITOR
PIE12)
4drt DE NOVO DESIGNED
SERINE HYDROLASE,
OR89

(synthetic
construct)
3 / 3 LEU A 256
TRP A 259
GLY A  12
None
0.75A 3l35A-4drtA:
undetectable
3l35H-4drtA:
undetectable
3l35A-4drtA:
7.76
3l35H-4drtA:
3.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3L35_K_DHIK3_0
(GP41 N-PEPTIDE
HIV ENTRY INHIBITOR
PIE12)
4drt DE NOVO DESIGNED
SERINE HYDROLASE,
OR89

(synthetic
construct)
3 / 3 LEU A 256
TRP A 259
GLY A  12
None
0.73A 3l35B-4drtA:
undetectable
3l35K-4drtA:
undetectable
3l35B-4drtA:
7.76
3l35K-4drtA:
3.74
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3NU4_B_478B401_1
(PROTEASE)
4drt DE NOVO DESIGNED
SERINE HYDROLASE,
OR89

(synthetic
construct)
5 / 9 ALA A  76
GLY A 112
ILE A 107
VAL A  98
ILE A  72
None
1.06A 3nu4A-4drtA:
undetectable
3nu4A-4drtA:
15.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3NUO_B_478B478_1
(PROTEASE)
4drt DE NOVO DESIGNED
SERINE HYDROLASE,
OR89

(synthetic
construct)
5 / 9 ALA A  76
GLY A 112
ILE A 107
VAL A  98
ILE A  72
None
1.10A 3nuoA-4drtA:
undetectable
3nuoA-4drtA:
15.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3VW1_D_CVID301_1
(PUTATIVE REGULATORY
PROTEIN)
4drt DE NOVO DESIGNED
SERINE HYDROLASE,
OR89

(synthetic
construct)
3 / 3 TYR A  26
MET A  50
LEU A 141
None
0.98A 3vw1D-4drtA:
undetectable
3vw1D-4drtA:
20.45
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4OQR_A_2UOA502_1
(CYP105AS1)
4drt DE NOVO DESIGNED
SERINE HYDROLASE,
OR89

(synthetic
construct)
5 / 9 VAL A  13
VAL A 240
ALA A 239
VAL A  31
ALA A  33
None
1.09A 4oqrA-4drtA:
undetectable
4oqrA-4drtA:
21.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4Q1W_A_017A104_2
(ASPARTYL PROTEASE)
4drt DE NOVO DESIGNED
SERINE HYDROLASE,
OR89

(synthetic
construct)
5 / 10 ALA A  76
GLY A 112
ILE A 107
VAL A  98
ILE A  72
None
1.06A 4q1wB-4drtA:
undetectable
4q1wB-4drtA:
15.38
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4UDC_A_DEXA1778_2
(GLUCOCORTICOID
RECEPTOR)
4drt DE NOVO DESIGNED
SERINE HYDROLASE,
OR89

(synthetic
construct)
3 / 3 MET A 119
GLN A  57
TYR A  53
None
CL  A 402 (-3.5A)
None
0.97A 4udcA-4drtA:
undetectable
4udcA-4drtA:
21.08
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5IM2_A_BEZA401_0
(TWIN-ARGININE
TRANSLOCATION
PATHWAY SIGNAL)
4drt DE NOVO DESIGNED
SERINE HYDROLASE,
OR89

(synthetic
construct)
5 / 12 ILE A 353
LEU A 320
LEU A 291
VAL A 330
GLN A 328
None
1.25A 5im2A-4drtA:
undetectable
5im2A-4drtA:
21.07
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5MSD_A_BEZA1202_0
(CARBOXYLIC ACID
REDUCTASE)
4drt DE NOVO DESIGNED
SERINE HYDROLASE,
OR89

(synthetic
construct)
4 / 5 HIS A  48
ILE A 107
SER A 152
ALA A 115
None
1.13A 5msdA-4drtA:
undetectable
5msdA-4drtA:
16.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VOP_A_C2FA3001_0
(5-METHYLTETRAHYDROFO
LATE HOMOCYSTEINE
S-METHYLTRANSFERASE)
4drt DE NOVO DESIGNED
SERINE HYDROLASE,
OR89

(synthetic
construct)
5 / 12 GLY A 216
LEU A 257
GLY A 212
ASN A 200
ILE A 213
None
1.04A 5vopA-4drtA:
undetectable
5vopA-4drtA:
23.54
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5VOP_B_C2FB3001_0
(5-METHYLTETRAHYDROFO
LATE HOMOCYSTEINE
S-METHYLTRANSFERASE)
4drt DE NOVO DESIGNED
SERINE HYDROLASE,
OR89

(synthetic
construct)
5 / 12 GLY A 216
LEU A 257
GLY A 212
ASN A 200
ILE A 213
None
1.12A 5vopB-4drtA:
undetectable
5vopB-4drtA:
23.54